Načítá se...

Breast cancer susceptibility associated with rs1219648 (FGFR2) and postmenopausal hormone therapy use in a population-based U.S. study

OBJECTIVE: Genome-wide association studies have consistently found variants in FGFR2 to be associated with breast cancer. Recent reports suggest that postmenopausal hormone therapy use may modify the association between single nucleotide polymorphisms in FGFR2 and breast cancer risk. We assessed the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Andersen, Shaneda Warren, Trentham-Dietz, Amy, Figueroa, Jonine D, Titus, Linda J, Cai, Qiuyin, Long, Jirong, Hampton, John M, Egan, Kathleen M, Newcomb, Polly A
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3549049/
https://ncbi.nlm.nih.gov/pubmed/23435034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0b013e318268ca46
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!